Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

TMDX

+ Watchlist+ Portfolio

TransMedics Group, Inc.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$96.43
52-Week Range
$60.11 – $156.00
Market Cap
$3.27B
P/E (TTM)
25.62
EPS (TTM)
3.67
Dividend Yield
0.00%
Advanced Metrics
Price/Book
5.93
PEG Ratio
0.96
Return on Equity
31.89%
Return on Assets
4.39%
Gross Margin
58.60%
Operating Margin
11.88%
Profit Margin
19.85%
Current Ratio
4.53
Debt/Equity
1.57
Total Debt
$866.90M
Free Cash Flow
$28.15M
Revenue Growth
41.10%
Earnings Growth
-29.80%
Enterprise Value
$3.72B

Market Snapshot

About

TransMedics Group, Inc. is a medical technology company revolutionizing organ transplant therapy for end-stage organ failure patients. The company has developed the Organ Care System, a portable extracorporeal warm perfusion and assessment platform that maintains donor organs in a near-physiologic state outside the body.